Skip to main content
TipRanks
Go Ultimate75% OFF

Summit Therapeutics (SMMT) Income Statement

2,045 Followers

Summit Therapeutics Income Statement

Last quarter (Q3 2026), Summit Therapeutics's total revenue was £0.00. In Q3, Summit Therapeutics's net income was £-208.38M. See Summit Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
£ 0.00£ 0.00£ 0.00£ 705.00K£ 1.81M
£ 0.00£ 0.00£ 0.00£ 705.00K£ 1.81M
£ 1.09B£ 226.00M£ 609.65M£ 72.79M£ 88.00M
Depreciation and Amortization£ 146.00K£ 111.00K£ 252.00K£ 1.53M£ 3.32M
£ -1.08B£ -210.88M£ -88.48M£ -62.09M£ -85.00M
£ -1.09B£ -226.00M£ -609.65M£ -72.09M£ -86.19M
£ 14.84M£ 4.68M£ -5.28M£ -6.69M£ -2.42M
£ -1.08B£ -221.31M£ -614.93M£ -78.78M£ -88.60M
£ -1.08B£ -221.31M£ -614.93M£ -78.78M£ -88.60M
Per Share Metrics
Basic EPS£ -1.44£ -0.31£ -0.99£ -0.41£ -0.96
Diluted EPS£ -1.44£ -0.31£ -0.99£ -0.41£ -0.96
Weighted Average Shares Outstanding747.70M713.92M619.64M192.15M92.24M
Weighted Average Shares Outstanding (Diluted)747.70M718.54M619.65M193.34M92.24M

Currency in GBP

Summit Therapeutics Earnings and Revenue History

-1.2B-600M0600M-12000 %-6000 %0 %6000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin